Electrosprayed co-crystals of levofloxacin for inhalation: a strategy for excipient-free dry powder antibiotics
Abstract
Pulmonary delivery of antibiotics provides a targeted means of treating lower respiratory tract infections, yet the development of dry powder inhaler (DPI) formulations is limited by the poor aqueous solubility and physical instability of many active pharmaceutical ingredients. Here, we report a dual-platform strategy that combines mechanochemical co-crystallisation and electrospraying to produce, for the first time, an excipient-free inhalable formulation of levofloxacin (LEV). Three GRAS-listed co-formers-fumaric acid, salicylic acid, and isonicotinic acid-were screened using liquid-assisted grinding. Co-crystals of LEV with salicylic acid (SA) and isonicotinic acid (IN) were identified as crystalline, thermally stable, and physically robust. These co-crystals were processed via cone-jet electrospraying, yielding uniform, spherical microparticles with aerodynamic diameters below 5 µm, suitable for deep-lung deposition. Powder X-ray diffraction and microscopy confirmed that co-crystal integrity and morphology were preserved throughout electrospraying. This work establishes a scalable, low-temperature manufacturing platform for producing high-performance, excipient-free inhalable antibiotics. Beyond levofloxacin, this approach provides a general framework for on-demand, personalised pulmonary drug delivery, bridging solid-state chemistry with advanced particle engineering.
Read the paper
Related studies
- Ferulic acid regulates the AKT/GSK-3β/CRMP-2 signaling pathway in a middle cerebral artery occlusion animal model
- Novel Pharmacokinetic/Pharmacodynamic Parameters Quantify the Exposure–Effect Relationship of Levofloxacin against Fluoroquinolone-Resistant Escherichia coli
- Photochemical behavior of levofloxacin
- Correlation Between Dissolution Profiles of Salt-Form Drugs in Biorelevant Bicarbonate Buffer and Oral Drug Absorption: Importance of Dose/ Fluid Volume Ratio
- Evaluation of the synergistic potential and mechanisms of action for de novo designed cationic antimicrobial peptides
- Synthesis of [11C]levofloxacin
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.